Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

<p><strong>BACKGROUND:</strong><em>Plasmodium vivax</em> malaria remains a major public health burden in Myanmar. Resistance to chloroquine (CQ), the first-line treatment for <em>P. vivax</em>, has been reported in the country and has potential to undermine...

ver descrição completa

Detalhes bibliográficos
Principais autores: Htun, M, Mon, N, Aye, K, Hlaing, C, Kyaw, M, Handayuni, I, Trimarsanto, H, Bustos, D, Ringwald, P, Price, R, Auburn, S, Thriemer, K
Formato: Journal article
Idioma:English
Publicado em: BioMed Central 2017

Registros relacionados

Registros relacionados